140 related articles for article (PubMed ID: 38240497)
1. A quaternary ammonium-based nanosystem enables delivery of CRISPR/Cas9 for cancer therapy.
Zhang M; Sun S; Liang X; Liu Z; Yin J; Li Q; Yang S
Biomater Sci; 2024 Feb; 12(5):1197-1210. PubMed ID: 38240497
[TBL] [Abstract][Full Text] [Related]
2. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical and Functional Characterization of Differential CRISPR-Cas9 Ribonucleoprotein Complexes.
Camperi J; Moshref M; Dai L; Lee HY
Anal Chem; 2022 Jan; 94(2):1432-1440. PubMed ID: 34958212
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
[TBL] [Abstract][Full Text] [Related]
5. Targeted Genome Editing Using DNA-Free RNA-Guided Cas9 Ribonucleoprotein for CHO Cell Engineering.
Shin J; Lee N; Cho S; Cho BK
Methods Mol Biol; 2018; 1772():151-169. PubMed ID: 29754227
[TBL] [Abstract][Full Text] [Related]
6. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
Zhang S; Shen J; Li D; Cheng Y
Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496
[TBL] [Abstract][Full Text] [Related]
7. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
[TBL] [Abstract][Full Text] [Related]
8. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
[TBL] [Abstract][Full Text] [Related]
9. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
Chen S; Lee B; Lee AY; Modzelewski AJ; He L
J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
[TBL] [Abstract][Full Text] [Related]
10. An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells.
Ye Y; Zhang X; Xie F; Xu B; Xie P; Yang T; Shi Q; Zhang CY; Zhang Y; Chen J; Jiang X; Li J
Biomater Sci; 2020 May; 8(10):2966-2976. PubMed ID: 32342086
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9.
Hosseini ES; Nikkhah M; Hosseinkhani S
Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265
[No Abstract] [Full Text] [Related]
12. Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application.
Sun B; Chen H; Gao X
J Control Release; 2021 Sep; 337():698-717. PubMed ID: 34364918
[TBL] [Abstract][Full Text] [Related]
13. Development of a pVEC peptide-based ribonucleoprotein (RNP) delivery system for genome editing using CRISPR/Cas9 in Chlamydomonas reinhardtii.
Kang S; Jeon S; Kim S; Chang YK; Kim YC
Sci Rep; 2020 Dec; 10(1):22158. PubMed ID: 33335164
[TBL] [Abstract][Full Text] [Related]
14. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
Bykonya AG; Lavrov AV; Smirnikhina SA
Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
[TBL] [Abstract][Full Text] [Related]
15. Genome Editing in Chlamydomonas reinhardtii Using Cas9-gRNA Ribonucleoprotein Complex: A Step-by-Step Guide.
Dhokane D; Kancharla N; Savarimuthu A; Bhadra B; Bandyopadhyay A; Dasgupta S
Methods Mol Biol; 2023; 2653():207-217. PubMed ID: 36995629
[TBL] [Abstract][Full Text] [Related]
16. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
17. Scaffold-Based Delivery of CRISPR/Cas9 Ribonucleoproteins for Genome Editing.
Chooi WH; Chin JS; Chew SY
Methods Mol Biol; 2021; 2211():183-191. PubMed ID: 33336278
[TBL] [Abstract][Full Text] [Related]
18. Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain.
Abbasi S; Uchida S; Toh K; Tockary TA; Dirisala A; Hayashi K; Fukushima S; Kataoka K
J Control Release; 2021 Apr; 332():260-268. PubMed ID: 33647431
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
20. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
Im SH; Jang M; Park JH; Chung HJ
J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
